No Data
No Data
Anhui Wanyi Science and Technology (688600.SH) has obtained the registration certificate for medical instruments.
Anhui Wanyi Science and Technology (688600.SH) announced that the company received a notice from the National Medical Products Administration on September 6, 2024...
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
Anhui Wanyi Science and Technology (688600.SH): The net loss in the first half of the year was 28.86 million yuan, turning from a profit to a loss year-on-year.
Gelonghui August 23 | Anhui Wanyi Science and Technology (688600.SH) released its semi-annual report, with revenue of 0.297 billion yuan, a 4.43% year-on-year decrease, a net loss of 28.86 million yuan, a year-on-year loss turnaround, a non-GAAP net loss of 36.42 million yuan, a year-on-year loss turnaround, basic earnings per share of -0.21 yuan.
Anhui Wanyi Science and Technology (688600.SH): has cumulatively repurchased 4.44% of its shares.
Anhui Wanyi Science and Technology (688600.SH) announced on August 2nd that as of July 31st, 2024, the company has cumulatively repurchased 5,981,226 shares through centralized bidding, accounting for 4.44% of the company's total share capital of 134,708,490 shares. The highest purchase price was 21.56 yuan/share and the lowest was 11.16 yuan/share. The total amount paid was 99,001,940.93 yuan (excluding stamp duty, transaction commission and other fees).
Anhui Wanyi Science and Technology (688600.SH): Plans to use up to 0.23 billion yuan of temporarily unused raised funds for cash management.
On July 12th, Glon Hui announced that Anhui Wanyi Science and Technology (688600.SH) held the 14th meeting of the fifth board of directors and the 12th meeting of the fifth supervisory board on July 12, 2024, and approved the proposal on the use of temporarily idle funds for cash management, agreeing that the company can use the temporarily idle funds raised, up to a maximum of RMB 230 million, for cash management, while ensuring that it does not affect the implementation of investment projects and ensuring the safety of raised funds. The funds will be used to purchase investment products with high safety, good liquidity, and guaranteed principal (including but not limited to structured products).
No Data
No Data